These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 18754005)

  • 1. Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum.
    Bossong MG; van Berckel BN; Boellaard R; Zuurman L; Schuit RC; Windhorst AD; van Gerven JM; Ramsey NF; Lammertsma AA; Kahn RS
    Neuropsychopharmacology; 2009 Feb; 34(3):759-66. PubMed ID: 18754005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further human evidence for striatal dopamine release induced by administration of ∆9-tetrahydrocannabinol (THC): selectivity to limbic striatum.
    Bossong MG; Mehta MA; van Berckel BN; Howes OD; Kahn RS; Stokes PR
    Psychopharmacology (Berl); 2015 Aug; 232(15):2723-9. PubMed ID: 25801289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can recreational doses of THC produce significant dopamine release in the human striatum?
    Stokes PR; Mehta MA; Curran HV; Breen G; Grasby PM
    Neuroimage; 2009 Oct; 48(1):186-90. PubMed ID: 19539765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic activity in Tourette syndrome and obsessive-compulsive disorder.
    Denys D; de Vries F; Cath D; Figee M; Vulink N; Veltman DJ; van der Doef TF; Boellaard R; Westenberg H; van Balkom A; Lammertsma AA; van Berckel BN
    Eur Neuropsychopharmacol; 2013 Nov; 23(11):1423-31. PubMed ID: 23876376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-dependent effects of repeated THC treatment on dopamine D2/3 receptor-mediated signalling in midbrain and striatum.
    Tournier BB; Tsartsalis S; Dimiziani A; Millet P; Ginovart N
    Behav Brain Res; 2016 Sep; 311():322-329. PubMed ID: 27233824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. History of cannabis use is not associated with alterations in striatal dopamine D2/D3 receptor availability.
    Stokes PR; Egerton A; Watson B; Reid A; Lappin J; Howes OD; Nutt DJ; Lingford-Hughes AR
    J Psychopharmacol; 2012 Jan; 26(1):144-9. PubMed ID: 21890594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dopamine stabilizer (-)-OSU6162 occupies a subpopulation of striatal dopamine D2/D3 receptors: an [(11)C]raclopride PET study in healthy human subjects.
    Tolboom N; Berendse HW; Leysen JE; Yaqub M; van Berckel BN; Schuit RC; Ponsen MM; Bakker E; Hoetjes NJ; Windhorst AD; Carlsson ML; Lammertsma AA; Carlsson A
    Neuropsychopharmacology; 2015 Jan; 40(2):472-9. PubMed ID: 25248987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Striatal D(2)/D(3) receptor availability is inversely correlated with cannabis consumption in chronic marijuana users.
    Albrecht DS; Skosnik PD; Vollmer JM; Brumbaugh MS; Perry KM; Mock BH; Zheng QH; Federici LA; Patton EA; Herring CM; Yoder KK
    Drug Alcohol Depend; 2013 Feb; 128(1-2):52-7. PubMed ID: 22909787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased synaptic dopamine function in associative regions of the striatum in schizophrenia.
    Kegeles LS; Abi-Dargham A; Frankle WG; Gil R; Cooper TB; Slifstein M; Hwang DR; Huang Y; Haber SN; Laruelle M
    Arch Gen Psychiatry; 2010 Mar; 67(3):231-9. PubMed ID: 20194823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET measures of amphetamine-induced dopamine release in ventral versus dorsal striatum.
    Drevets WC; Price JC; Kupfer DJ; Kinahan PE; Lopresti B; Holt D; Mathis C
    Neuropsychopharmacology; 1999 Dec; 21(6):694-709. PubMed ID: 10633475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower level of endogenous dopamine in patients with cocaine dependence: findings from PET imaging of D(2)/D(3) receptors following acute dopamine depletion.
    Martinez D; Greene K; Broft A; Kumar D; Liu F; Narendran R; Slifstein M; Van Heertum R; Kleber HD
    Am J Psychiatry; 2009 Oct; 166(10):1170-7. PubMed ID: 19723785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine Synthesis Capacity is Associated with D2/3 Receptor Binding but Not Dopamine Release.
    Berry AS; Shah VD; Furman DJ; White RL; Baker SL; O'Neil JP; Janabi M; D'Esposito M; Jagust WJ
    Neuropsychopharmacology; 2018 May; 43(6):1201-1211. PubMed ID: 28816243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term test-retest reliability of striatal and extrastriatal dopamine D2/3 receptor binding: study with [(11)C]raclopride and high-resolution PET.
    Alakurtti K; Johansson JJ; Joutsa J; Laine M; Bäckman L; Nyberg L; Rinne JO
    J Cereb Blood Flow Metab; 2015 Jul; 35(7):1199-205. PubMed ID: 25853904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Balanced modulation of striatal activation from D2 /D3 receptors in caudate and ventral striatum: Disruption in cannabis abusers.
    Tomasi D; Wang GJ; Volkow ND
    Hum Brain Mapp; 2015 Aug; 36(8):3154-66. PubMed ID: 26058801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine D(2/3) receptor availability and human cognitive impulsivity: a high-resolution positron emission tomography imaging study with [¹¹C]raclopride.
    Kim JH; Son YD; Kim HK; Lee SY; Kim YB; Cho ZH
    Acta Neuropsychiatr; 2014 Feb; 26(1):35-42. PubMed ID: 25142098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson's disease.
    Boileau I; Guttman M; Rusjan P; Adams JR; Houle S; Tong J; Hornykiewicz O; Furukawa Y; Wilson AA; Kapur S; Kish SJ
    Brain; 2009 May; 132(Pt 5):1366-75. PubMed ID: 19153147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring personality traits related to dopamine D2/3 receptor availability in striatal subregions of humans.
    Caravaggio F; Fervaha G; Chung JK; Gerretsen P; Nakajima S; Plitman E; Iwata Y; Wilson A; Graff-Guerrero A
    Eur Neuropsychopharmacol; 2016 Apr; 26(4):644-52. PubMed ID: 26944295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated putamen D(2) receptor binding potential in major depression with motor retardation: an [11C]raclopride positron emission tomography study.
    Meyer JH; McNeely HE; Sagrati S; Boovariwala A; Martin K; Verhoeff NP; Wilson AA; Houle S
    Am J Psychiatry; 2006 Sep; 163(9):1594-602. PubMed ID: 16946186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ketamine does not decrease striatal dopamine D2 receptor binding in man.
    Aalto S; Hirvonen J; Kajander J; Scheinin H; Någren K; Vilkman H; Gustafsson L; Syvälahti E; Hietala J
    Psychopharmacology (Berl); 2002 Dec; 164(4):401-6. PubMed ID: 12457270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naltrexone modulates dopamine release following chronic, but not acute amphetamine administration: a translational study.
    Jayaram-Lindström N; Guterstam J; Häggkvist J; Ericson M; Malmlöf T; Schilström B; Halldin C; Cervenka S; Saijo T; Nordström AL; Franck J
    Transl Psychiatry; 2017 Apr; 7(4):e1104. PubMed ID: 28440810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.